NILES, Ill., June 3, 2024 /PRNewswire/ -- Ashton-Drake, known for their realism and artistry in dolls and collectible figures, is proud to introduce their newest collector series—the "Rudolph the Red-Nosed Reindeer®" Masterpiece Figure Collection https://bit.ly/AshtonDrakeRudolphTheRedNosedReindeer. The culmination of countless hours of research, design work, and expert craftsmanship, each issue features authentic recreations of characters from the 1964 TV... (continue reading...)
The 2nd Ho Chi Minh City River Festival 2024 will take place from May 31 to June 9, 2024, featuring a series of exciting sports, entertainment, and artistic activities.
HO CHI MINH CITY, Vietnam, June 3, 2024 /PRNewswire/ -- Ho Chi Minh City always knows how to captivate visitors with its unique charm, vibrant lifestyle, and impressive cultural and historical heritage. Adding to its allure, the city's annual festivals have carved out a distinctive identity, drawing an... (continue reading...)
- Global PE looks to have arrested its freefall as the slide in dealmaking and exits levels off
- Buyout deal numbers set to stay flat vs 2023 with higher average deal size driving a rise in deal value
- Multiple challenges facing the sector put the premium for PE firms on adjusting to a new normal
BOSTON, June 3, 2024 /PRNewswire/ --The two-year long slump in global private equity looks finally to be bottoming out, with the industry finding a footing from which to climb... (continue reading...)
Photography News: Sigma has released a fast full-frame zoom offering a versatile focal length range, a bright f/1.8 design, and optical performance that rivals a prime.
NEW YORK, June 3, 2024 /PRNewswire/ -- B&H is pleased to share the new Sigma 28-45mm f/1.8 DG DN Art lens—a unique full-frame zoom that features a constant f/1.8 maximum aperture and a short wide-angle to normal-length zoom range. This lens is effectively the full-frame mirrorless successor to their... (continue reading...)
SALT LAKE CITY, June 3, 2024 /PRNewswire/ -- ARUP Laboratories is backing a federal lawsuit filed by the American Clinical Laboratory Association (ACLA) challenging the FDA's final rule to regulate laboratory-developed tests (LDTs) as medical devices. The lawsuit states that the FDA does not have legal authority over medical testing services from Congress and asserts that regulating these services is unreasonable.
More PRNewswire
View Older Stories-
10 Fitness Guarantees Uninterrupted Gym Access with SARA, Even After Hours
-
MGI Tech's DNBSEQ-E25 and G99 Platforms Set Record for Sequencing Applications on Mount Everest
-
The9 Signed a Definitive Share Purchase Agreement to Invest in AI-Powered Educational Technology Company
-
Leads Biolabs' Innovative Cancer Treatment LBL-024, an Anti-PDL1/4-1BB Bispecific Antibody Achieved Outstanding Phase II Results, Has Been Presented in Clinical Science Symposium at 2024 ASCO Ann
-
NOTICE OF THE TWENTY-FIFTH ANNUAL GENERAL MEETING OF SHAREHOLDERS
-
2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner
-
Supermicro Liquid-Cooled AI SuperClusters Will Power Large-Scale AI Data Center in Japan
-
LaVie Care Centers Takes Strategic Actions to Position the Company for Long-Term Success Amidst Challenging Skilled Nursing Operating Environment
-
Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatme
-
Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer a
-
China Medical University Hospital (CMUH, Taiwan) Signs MOU with Malaysian International Medical University
-
Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic Dermatitis
-
TECNO exhibits its diverse smartphone and AIoT ecosystem with futuristic AR and AI products at COMPUTEX Taipei 2024, with the concept "Smart of Creation"
-
MSI Unveils New AI and Computing Platforms with 4th Gen AMD EPYC™ Processors at Computex 2024
-
Fast Guard Service Shares Their Experience with Local Business Owner as the Best Security Guard Company in California
-
One in Five European Companies Are Facing Strong Pressure to Transform to Stay Viable
-
FrogData Unveils Major AI Factory Upgrade to Revolutionize Automotive Retail Operations
-
izmostock Unveils Revolutionary Image Solution for Leasing Industry, Driving Unparalleled ROI and User Engagement
-
GIGABYTE Partners with NVIDIA on RTX AI PCs Supporting ACE NIM and Digital Human Technology
-
Miami Beach Inspires this Summer with Film, Fashion and Music Experiences
-
Rokid AR Lite Crowdfunding Surpasses $600,000 with One Day Left for Early Bird Price of $479
-
Discovery of World War II fighter plane sets path for first U.S.-Papua New Guinea Sister City
-
Linker Vision to Accelerate Vision AI Adoption Across Enterprise Applications with Large Vision Models, in Collaboration with NVIDIA
-
ConcertAI to Advance Translational and Clinical Development Solutions in Collaboration with NVIDIA
-
ASRock Rack Launches New Servers Supporting the NVIDIA Blackwell Architecture at COMPUTEX 2024
-
MEDSIR's PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer
-
Flamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC)
-
Federal Government Authorizes Institute of Information Management to Certify Data Protection Professionals in Nigeria
-
Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care
-
Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Trend Micro to Secure AI-Enabled Private Data Centers Worldwide
-
Vention to democratize industrial automation using NVIDIA AI technologies
-
OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
-
Fast Guard Service Releases Guide to Choosing the Best Fire Watch Service
-
Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
-
Innovent Announces Taletrectinib(ROS1 Inhibitor)Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting
-
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC
-
Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
-
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
-
Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer
-
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting
-
Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting
-
GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a La
-
LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
-
Sun Bum Makes SPF Waves in Miami with its Largest Ever Beach Hangout for Skin Cancer Awareness Month
-
Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation
-
BIOHACKING CONFERENCE ANNOUNCES STEMREGENⓇ WILL RETURN AS TITLE SPONSOR FOR 2025
-
Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
-
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Upd
-
Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US